TOFACITINIB VERSUS BIOLOGIC TREATMENTS IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS WHO HAVE HAD AN INADEQUATE RESPONSE TO TUMOUR NECROSIS FACTOR INHIBITORS A NETWORK META-ANALYSIS

被引：0
|
作者：
Vieira, M. C. [1 ]
Wallenstein, G. [2 ]
Bradley, J. [2 ]
Gruben, D. [2 ]
Koncz, T. [3 ]
Zwillich, S. H. [2 ]
Jansen, J. P. [1 ]
机构：
[1] MAPI Consultancy, Boston, MA USA
[2] Pfizer Inc, Groton, CT 06340 USA
[3] Pfizer Inc, New York, NY USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷
关键词：
FACTOR THERAPY; DOUBLE-BLIND; TRIAL; MULTICENTER; RITUXIMAB; ABATACEPT; OUTCOMES;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：619 / 620
页数：2
相关论文
共 50 条
  • [1] Tofacitinib Versus Biologic Treatments in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Tumor Necrosis Factor Inhibitors: Results From a Network Meta-analysis
    Vieira, Maria-Cecilia
    Zwillich, Samuel H.
    Jansen, Jeroen P.
    Smiechowski, Brielan
    Spurden, Dean
    Wallenstein, Gene V.
    CLINICAL THERAPEUTICS, 2016, 38 (12) : 2628 - 2641
  • [2] TOFACITINIB VERSUS BIOLOGIC TREATMENTS IN MODERATE TO SEVERE RHEUMATOID ARTHRITIS PATIENTS WHO HAVE HAD AN INADEQUATE RESPONSE TO NONBIOLOGIC DMARDS: SYSTEMATIC LITERATURE REVIEW AND NETWORK META-ANALYSIS
    Bergrath, E.
    Wallenstein, G.
    Gerbert, R.
    Gruben, D.
    Makin, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 726 - 726
  • [3] TOFACITINIB VERSUS BIOLOGIC TREATMENTS WITH AND WITHOUT METHOTREXATE IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS WHO HAVE HAD AN INADEQUATE RESPONSE TO TRADITIONAL DISEASE MODIFYING ANTI-RHEUMATIC DRUGS - A NETWORK META-ANALYSIS
    Vieira, M. G.
    Wallenstein, G. V.
    Bradley, J. D.
    Gruben, D.
    Koncz, T.
    Zwillich, S. H.
    Jansen, J. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 375 - 375
  • [4] Network meta-analysis of tofacitinib versus biologic treatments in moderate-to-severe rheumatoid arthritis patients
    Camean-Castillo, Manuel
    Gimeno-Ballester, Vicente
    Rios-Sanchez, Esmeralda
    Fenix-Caballero, Silvia
    Vazquez-Real, Miguel
    Alegre-del Rey, Emilio
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2019, 44 (03) : 384 - 396
  • [5] The efficacy of biologic agents in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors: a systematic review
    Moots, Robert J.
    Naisbett-Groet, Barbara
    RHEUMATOLOGY, 2012, 51 (12) : 2252 - 2261
  • [6] A review of tofacitinib efficacy in rheumatoid arthritis patients who have had an inadequate response or intolerance to methotrexate
    Fleischmann, Roy
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (14) : 1525 - 1533
  • [7] Comparative efficacy and safety of biologic agents in patients with active rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitors: A Bayesian network meta-analysis of randomized controlled trials
    Sung, Yoon-Kyoung
    Lee, Young Ho
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2022, 60 (01) : 13 - 23
  • [8] SAFETY AND EFFICACY OF OCRELIZUMAB IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE RESPONSE TO METHOTREXATE OR TUMOUR NECROSIS FACTOR INHIBITORS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Ahmed, Hussien
    Abushouk, Abdelrahman Ibrahim
    Ismail, Ammar
    Elmaraezy, Ahmed
    Badr, Ahmed Said
    Gadelkarim, Mohamed
    Elnenny, Mohammed
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : A8 - A8
  • [9] Tofacitinib for acute rheumatoid arthritis patients who have had an inadequate response to disease-modifying antirheumatic drug (DMARD): a systematic review and meta-analysis
    Zhang, Xingming
    Liang, Fuxiang
    Yin, Xiaoxue
    Xiao, Juan
    Shi, Peiyu
    Wei, Dang
    Yao, Liang
    Wang, Qi
    Chen, Yaolong
    CLINICAL RHEUMATOLOGY, 2014, 33 (02) : 165 - 173
  • [10] Tofacitinib for acute rheumatoid arthritis patients who have had an inadequate response to disease-modifying antirheumatic drug (DMARD): a systematic review and meta-analysis
    Xingming Zhang
    Fuxiang Liang
    Xiaoxue Yin
    Xiaojuan Xiao
    Peiyu Shi
    Dang Wei
    Liang Yao
    Qi Wang
    Yaolong Chen
    Clinical Rheumatology, 2014, 33 : 165 - 173
12345